AU1628101A - Jaffa, a novel fibroblast growth factor family member and uses therefor - Google Patents

Jaffa, a novel fibroblast growth factor family member and uses therefor

Info

Publication number
AU1628101A
AU1628101A AU16281/01A AU1628101A AU1628101A AU 1628101 A AU1628101 A AU 1628101A AU 16281/01 A AU16281/01 A AU 16281/01A AU 1628101 A AU1628101 A AU 1628101A AU 1628101 A AU1628101 A AU 1628101A
Authority
AU
Australia
Prior art keywords
jaffa
growth factor
fibroblast growth
family member
factor family
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU16281/01A
Inventor
Mehran Mohamad Khodadoust
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Millennium Pharmaceuticals Inc
Original Assignee
Millennium Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Millennium Pharmaceuticals Inc filed Critical Millennium Pharmaceuticals Inc
Publication of AU1628101A publication Critical patent/AU1628101A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/50—Fibroblast growth factor [FGF]
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU16281/01A 1999-11-22 2000-11-22 Jaffa, a novel fibroblast growth factor family member and uses therefor Abandoned AU1628101A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US44416599A 1999-11-22 1999-11-22
US09444165 1999-11-22
PCT/US2000/032181 WO2001038357A2 (en) 1999-11-22 2000-11-22 Jaffa, a novel fibroblast growth factor family member and uses therefor

Publications (1)

Publication Number Publication Date
AU1628101A true AU1628101A (en) 2001-06-04

Family

ID=23763768

Family Applications (1)

Application Number Title Priority Date Filing Date
AU16281/01A Abandoned AU1628101A (en) 1999-11-22 2000-11-22 Jaffa, a novel fibroblast growth factor family member and uses therefor

Country Status (2)

Country Link
AU (1) AU1628101A (en)
WO (1) WO2001038357A2 (en)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7408047B1 (en) 1999-09-07 2008-08-05 Amgen Inc. Fibroblast growth factor-like polypeptides
US7459540B1 (en) * 1999-09-07 2008-12-02 Amgen Inc. Fibroblast growth factor-like polypeptides
US20040215007A1 (en) * 2001-09-28 2004-10-28 Su Eric Wen Novel secreted proteins and their uses
IL149562A0 (en) 2002-05-09 2002-11-10 Prochon Ltd Fgf variants and methods for use thereof
US7067123B2 (en) 2003-04-29 2006-06-27 Musculoskeletal Transplant Foundation Glue for cartilage repair
US7901457B2 (en) 2003-05-16 2011-03-08 Musculoskeletal Transplant Foundation Cartilage allograft plug
WO2006028714A1 (en) * 2004-09-02 2006-03-16 Eli Lilly And Company Muteins of fibroblast growth factor 21
CA2575753A1 (en) 2004-09-02 2006-03-16 Eli Lilly And Company Muteins of fibroblast growth factor 21
US7837740B2 (en) 2007-01-24 2010-11-23 Musculoskeletal Transplant Foundation Two piece cancellous construct for cartilage repair
US7815926B2 (en) 2005-07-11 2010-10-19 Musculoskeletal Transplant Foundation Implant for articular cartilage repair
EP1926459B1 (en) 2005-09-19 2015-01-07 Histogenics Corporation Cell-support matrix having narrowly defined uniformly vertically and non-randomly organized porosity and pore density and a method for preparation thereof
US8435551B2 (en) 2007-03-06 2013-05-07 Musculoskeletal Transplant Foundation Cancellous construct with support ring for repair of osteochondral defects
BRPI0812384A2 (en) * 2007-05-22 2014-12-02 Novartis Ag TREATMENT, DIAGNOSTIC AND DISEASE TREATMENT METHODS ASSOCIATED WITH FGF21
US8685107B2 (en) 2007-07-03 2014-04-01 Histogenics Corporation Double-structured tissue implant and a method for preparation and use thereof
US20090054984A1 (en) 2007-08-20 2009-02-26 Histogenics Corporation Method For Use Of A Double-Structured Tissue Implant For Treatment Of Tissue Defects
WO2009111069A1 (en) 2008-03-05 2009-09-11 Musculoskeletal Transplant Foundation Cancellous constructs, cartilage particles and combinations of cancellous constructs and cartilage particles
JOP20190083A1 (en) 2008-06-04 2017-06-16 Amgen Inc Fgf21 mutant fusion polypeptides and uses thereof
WO2010042747A2 (en) 2008-10-10 2010-04-15 Amgen Inc. Fgf21 mutants and uses thereof
MX2011011815A (en) 2009-05-05 2012-01-27 Amgen Inc Fgf21 mutants and uses thereof.
JO3469B1 (en) 2009-05-05 2020-07-05 Amgen Inc Fgf21 mutants and uses thereof
UA109888C2 (en) 2009-12-07 2015-10-26 ANTIBODY OR ANTIBODILITY ANTIBODY OR ITS BINDING TO THE β-CLOTE, FGF RECEPTORS AND THEIR COMPLEXES
CA2796055A1 (en) 2010-04-15 2011-10-20 Amgen Inc. Human fgf receptor and .beta.-klotho binding proteins
US10077420B2 (en) 2014-12-02 2018-09-18 Histogenics Corporation Cell and tissue culture container
BR112019023260A2 (en) 2017-05-05 2022-02-22 Trefoil Therapeutics, Inc. MODIFIED RECOMBINANT FIBROBLAST GROWTH FACTORS AND THEIR THERAPEUTIC USES

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010006939A1 (en) * 1997-10-03 2001-07-05 Ralph W. Niven Secretory leukocyte protease inhibitor dry powder pharmaceutical compositions

Also Published As

Publication number Publication date
WO2001038357A2 (en) 2001-05-31
WO2001038357A3 (en) 2001-10-18

Similar Documents

Publication Publication Date Title
AU1628101A (en) Jaffa, a novel fibroblast growth factor family member and uses therefor
AU3924300A (en) Fibroblast growth factor-20
AU3224700A (en) Fibroblast growth factor receptor-immunoglobulin fusion
AU5056501A (en) Fibroblast growth factor-like molecules and uses thereof
AUPR030900A0 (en) Growth factor complex
AU4431000A (en) Novel use
AU4157000A (en) Balanced inductor
IL156259A0 (en) Novel fibroblast growth factors
AU2001240149A1 (en) Fibroblast growth factor-like molecules and uses thereof
AU6635800A (en) Pyridomorphinans, thienomoprhinans and use thereof
AU4688499A (en) Fibroblast growth factor receptor-5
AU8586198A (en) Growth differentiation factor, lefty-1
AU8580098A (en) Growth differentiation factor, lefty-2
AU7053500A (en) Chymotrypsin-free trypsin
AU8018200A (en) A knowledge-engineering protocol-suite
AU5440800A (en) Fibroblast growth factor 10
AU5998900A (en) A valve
AU4851200A (en) Fibroblast growth factor 11
AU6984800A (en) Valve
AU5903600A (en) A novel vascular endothelial growth factor family member and uses thereof
AU6748400A (en) A single-compiler architecture
AU6951400A (en) Fibroblast growth factor 13
AU5019700A (en) Fibroblast growth factor 14
AU1686701A (en) Dispatched polypeptides
AU4649600A (en) Bridge-1, a transcription factor

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase